The NHS has launched a groundbreaking vaccination program for high-risk individuals in England, targeting gonorrhoea, a sexually transmitted infection with rising cases, particularly among gay and bisexual men. The 4CMenB vaccine aims to prevent up to 100,000 infections, alleviate NHS pressure, and combat antibiotic-resistant strains, as diagnoses reached a record 85,000 in 2023.
